Compositions and methods for inhibition of the JAK pathway

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9920041
SERIAL NO

15439705

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful. Also disclosed are methods of making the compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RIGEL PHARMACEUTICALS INC1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Yan Foster City, US 884 10448
Ding, Pingyu Foster City, US 61 697
Heckrodt, Thilo J San Francisco, US 36 627
Li, Hui Santa Clara, US 1361 15841
McMurtrie, Darren John Daly City, US 9 74
Singh, Rajinder Belmont, US 480 10970
Taylor, Vanessa San Francisco, US 116 1737
Yen, Rose San Francisco, US 59 246

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00